These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 29414455)

  • 1. Aspirin exacerbated respiratory disease: Current topics and trends.
    Rodríguez-Jiménez JC; Moreno-Paz FJ; Terán LM; Guaní-Guerra E
    Respir Med; 2018 Feb; 135():62-75. PubMed ID: 29414455
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aspirin-exacerbated respiratory disease and current treatment modalities.
    Sakalar EG; Muluk NB; Kar M; Cingi C
    Eur Arch Otorhinolaryngol; 2017 Mar; 274(3):1291-1300. PubMed ID: 27538737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aspirin-Exacerbated Respiratory Disease and the Unified Airway: A Contemporary Review.
    Walters BK; Hagan JB; Divekar RD; Willson TJ; Stokken JK; Pinheiro-Neto CD; O'Brien EK; Choby G
    Otolaryngol Clin North Am; 2023 Feb; 56(1):107-124. PubMed ID: 36283868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aspirin-exacerbated respiratory disease: characteristics and management strategies.
    Simon RA; Dazy KM; Waldram JD
    Expert Rev Clin Immunol; 2015; 11(7):805-17. PubMed ID: 25936612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of Aspirin-Exacerbated Respiratory Disease: What Does the Future Hold?
    O'Brien EK; Jerschow E; Divekar RD
    Otolaryngol Clin North Am; 2024 Apr; 57(2):265-278. PubMed ID: 37833102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current complications and treatment of aspirin-exacerbated respiratory disease.
    Cook KA; Stevenson DD
    Expert Rev Respir Med; 2016 Dec; 10(12):1305-1316. PubMed ID: 27817219
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of aspirin desensitization in patients with aspirin-exacerbated respiratory disease (AERD).
    Spies JW; Valera FC; Cordeiro DL; de Mendonça TN; Leite MG; Tamashiro E; Arruda LK; Anselmo-Lima WT
    Braz J Otorhinolaryngol; 2016; 82(3):263-8. PubMed ID: 26601997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Not Available].
    Borgeat Kaeser A; Ribi C
    Praxis (Bern 1994); 2017; 106(22):1243-1249. PubMed ID: 29088964
    [No Abstract]   [Full Text] [Related]  

  • 9. Aspirin Actions in Treatment of NSAID-Exacerbated Respiratory Disease.
    Sehanobish E; Asad M; Barbi M; Porcelli SA; Jerschow E
    Front Immunol; 2021; 12():695815. PubMed ID: 34305932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aspirin-sensitive rhinosinusitis and asthma.
    Kowalski ML
    Clin Allergy Immunol; 2007; 19():147-75. PubMed ID: 17153012
    [No Abstract]   [Full Text] [Related]  

  • 11. Long-term Clinical Outcomes of Aspirin Desensitization With Continuous Daily Aspirin Therapy in Aspirin-exacerbated Respiratory Disease.
    Walters KM; Waldram JD; Woessner KM; White AA
    Am J Rhinol Allergy; 2018 Jul; 32(4):280-286. PubMed ID: 29682983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical evaluation and diagnosis of aspirin-exacerbated respiratory disease.
    Haque R; White AA; Jackson DJ; Hopkins C
    J Allergy Clin Immunol; 2021 Aug; 148(2):283-291. PubMed ID: 34364538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A retrospective analysis of esophageal eosinophilia in patients with aspirin-exacerbated respiratory disease.
    Eid RC; Palumbo ML; Laidlaw TM; Buchheit KM; Cahill KN
    J Allergy Clin Immunol Pract; 2019 Apr; 7(4):1338-1340. PubMed ID: 30261317
    [No Abstract]   [Full Text] [Related]  

  • 14. Thymic stromal lymphopoietin controls prostaglandin D2 generation in patients with aspirin-exacerbated respiratory disease.
    Buchheit KM; Cahill KN; Katz HR; Murphy KC; Feng C; Lee-Sarwar K; Lai J; Bhattacharyya N; Israel E; Boyce JA; Laidlaw TM
    J Allergy Clin Immunol; 2016 May; 137(5):1566-1576.e5. PubMed ID: 26691435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Objective and subjective sinonasal and pulmonary outcomes in aspirin desensitization therapy: A prospective cohort study.
    Cooper T; Greig SR; Zhang H; Seemann R; Wright ED; Vliagoftis H; Côté DWJ
    Auris Nasus Larynx; 2019 Aug; 46(4):526-532. PubMed ID: 30577986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A 1-Day, 90-Minute Aspirin Challenge and Desensitization Protocol in Aspirin-Exacerbated Respiratory Disease.
    DeGregorio GA; Singer J; Cahill KN; Laidlaw T
    J Allergy Clin Immunol Pract; 2019 Apr; 7(4):1174-1180. PubMed ID: 30391549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rhinosinusitis and nasal polyps in aspirin-exacerbated respiratory disease.
    Mullol J; Picado C
    Immunol Allergy Clin North Am; 2013 May; 33(2):163-76. PubMed ID: 23639706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aspirin or other nonsteroidal inflammatory agent exacerbated asthma.
    Ledford DK; Wenzel SE; Lockey RF
    J Allergy Clin Immunol Pract; 2014; 2(6):653-7. PubMed ID: 25439353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Upper airways in aspirin-exacerbated respiratory disease.
    Choi JH; Kim JH; Park HS
    Curr Opin Allergy Clin Immunol; 2015 Feb; 15(1):21-6. PubMed ID: 25546326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aspirin-Exacerbated Respiratory Disease.
    Walgama ES; Hwang PH
    Otolaryngol Clin North Am; 2017 Feb; 50(1):83-94. PubMed ID: 27888917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.